ArticleJournal of inflammation research2025
Prognostic Value of Inflammatory Indices in Papillary Gastric Carcinoma with Different Proportions of Papillary Components.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate the prognostic significance of peripheral inflammatory indices in patients with advantage papillary gastric carcinoma (APGC) and non-advantage papillary gastric carcinoma (NAPGC). Methods: The study retrospectively analyzed 270 patients who underwent radical surgery. Patients were stratified into APGC (n=133) and NAPGC (n=137) cohorts based on papillary component proportion (≥50% papillary histology for APGC, <50% for NAPGC). Receiver operating characteristic curve analysis was performed to assess the sensitivity of inflammatory indices for prognostic prediction. Overall survival was analyzed using Kaplan‒Meier survival and Log rank tests. The relationship between inflammatory indicators and clinicopathological characteristics was examined. Independent prognostic risk factors were identified using the Cox regression model and integrated into a nomogram, with calibration plots and decision curves used to evaluate predictive performance. Results: Compared to NAPGC patients, APGC patients demonstrated higher pT stage and carcinoembryonic antigen (CEA) levels, with poorer survival outcomes. Stage III APGC patients showed higher peripheral blood neutrophil ratios than NAPGC patients. For APGC, neutrophil-to-lymphocyte ratio (NLR) and CEA were identified as independent prognostic factors, while for NAPGC, systemic immune-inflammatory index (SII), age, and pN stage were determined to be independent prognostic factors. Conclusion: Significant differences exist in clinicopathological characteristics, peripheral blood inflammatory indices, and prognosis between APGC and NAPGC patients. The nomogram incorporating inflammatory indices NLR and SII effectively predicts prognosis in both APGC and NAPGC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.